About Maxygen (NASDAQ:MAXY)
Maxygen, Inc. (Maxygen) is a biotechnology company focused on the development of its MAXY-G34 product candidate. MAXY-G34 is a pegylated, granulocyte colony stimulating factor (G-CSF), for the treatment of chemotherapy-induced neutropenia and acute radiation syndrome (ARS). On May 16, 2011, Astellas Pharma Inc. (Astellas) acquired the Company's interests in Perseid Therapeutics LLC, the Company's former subsidiary, which included all of the Company's research and development operations. As a result of the transaction, the Company has reclassified the operating results of Perseid, as well as any related business activities, to discontinued operations. The Company's wholly owned subsidiaries include Maxygen Holdings (U.S.), Inc., Maxygen ApS and Maxygen Holdings, Inc., and its majority owned subsidiary, Maxygen Holdings LLC.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Maxygen (NASDAQ:MAXY) Frequently Asked Questions
What is Maxygen's stock symbol?
Maxygen trades on the NASDAQ under the ticker symbol "MAXY."
Who are some of Maxygen's key competitors?
Some companies that are related to Maxygen include CSL (CSL), Grifols SA, Barcelona (GRFS), Jazz Pharmaceuticals (JAZZ), Sirtex Medical (SRX), ProMetic Life Sciences (PLI), Mirati Therapeutics (MRTX), Theratechnologies (TH), Organigram (OGI), SIGA Technologies (SIGA), Sevion Therapeutics (SVON), Osiris Therapeutics (OSIR), VBI Vaccines (VBIV), XOMA (XOMA), NAPEC (NPC), Medgenics (GNMX), ContraFect (CFRX), Anavex Life Sciences (AVXL) and Trillium Therapeutics (TRIL).
How do I buy Maxygen stock?
Shares of Maxygen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Maxygen?
Maxygen's mailing address is Suite 616, 411 Borel Avenue, SAN MATEO, CA 94402, United States. The biotechnology company can be reached via phone at +1-650-2412292.
MarketBeat Community Rating for Maxygen (MAXY)MarketBeat's community ratings are surveys of what our community members think about Maxygen and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Maxygen (NASDAQ:MAXY) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Maxygen (NASDAQ:MAXY) Earnings History and Estimates Chart
Maxygen (NASDAQ MAXY) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Maxygen (NASDAQ:MAXY) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Maxygen (NASDAQ:MAXY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Maxygen (NASDAQ MAXY)
No insider trades for this company have been tracked by MarketBeat.com
Maxygen (NASDAQ MAXY) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Maxygen (NASDAQ:MAXY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Maxygen (NASDAQ:MAXY) Income Statement, Balance Sheet and Cash Flow Statement
Maxygen (NASDAQ MAXY) Stock Chart for Wednesday, February, 21, 2018